[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@flobrand Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::86717586.png) @flobrand Florian Brand

Florian Brand posts on X about $2b, $459m, $405m, $184b the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::86717586/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::86717586/c:line/m:interactions.svg)

- X Week XXXXX +9,354%
- X Month XXXXX +631%
- X Months XXXXXX +12,665%
- X Year XXXXXX +1,310%

### Mentions: X [#](/creator/twitter::86717586/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::86717586/c:line/m:posts_active.svg)

- X Week X +167%
- X Month X +60%
- X Months XX +1,325%
- X Year XX +771%

### Followers: XXXXX [#](/creator/twitter::86717586/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::86717586/c:line/m:followers.svg)

- X Week XXXXX +0.65%
- X Month XXXXX +0.92%
- X Months XXXXX +9.10%
- X Year XXXXX +7.80%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::86717586/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::86717586/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::86717586/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [technology brands](/list/technology-brands)  XXXX%

**Social topic influence**
[$2b](/topic/$2b) 6.67%, [$459m](/topic/$459m) 6.67%, [$405m](/topic/$405m) 6.67%, [$184b](/topic/$184b) 6.67%, [$17b](/topic/$17b) 6.67%, [$atai](/topic/$atai) 6.67%, [$cmps](/topic/$cmps) 6.67%, [$mnmd](/topic/$mnmd) 6.67%, [$ghrs](/topic/$ghrs) 6.67%, [$googl](/topic/$googl) XXXX%

**Top accounts mentioned or mentioned by**
[@atailife](/creator/undefined) [@4andahalffarm](/creator/undefined) [@compasspathway](/creator/undefined) [@beckleypsytech](/creator/undefined) [@srinigrao](/creator/undefined) [@ikkjrpp](/creator/undefined) [@nppjournal](/creator/undefined) [@draulio](/creator/undefined) [@harryneuros](/creator/undefined) [@beckleypsytechs](/creator/undefined) [@psychedalpha](/creator/undefined) [@joshhardman](/creator/undefined) [@hubermanlab](/creator/undefined) [@larswilde](/creator/undefined) [@fda](/creator/undefined) [@martymakary](/creator/undefined) [@atailifes](/creator/undefined) [@nidanews](/creator/undefined) [@cangermayer](/creator/undefined) [@tylerthe30518](/creator/undefined)

**Top assets mentioned**
[ATAI Life Sciences (ATAI)](/topic/$atai) [Alphabet Inc Class A (GOOGL)](/topic/$googl)
### Top Social Posts [#](/creator/twitter::86717586/posts)
---
Top posts by engagements in the last XX hours

"1/5 BREAKING: Another strong quarter for J&Js psychedelic-like blockbuster SPRAVATO with annualized run-rate now closer to $2B. Q325 WW sales: $459M (US $405M) +61% y/y. Simple annualized (4Q3) $1.84B; FY25 likely around $1.7B. $ATAI $CMPS $MNMD $GHRS"  
[X Link](https://x.com/flobrand/status/1978057131791163697) [@flobrand](/creator/x/flobrand) 2025-10-14T11:15Z 3415 followers, 4315 engagements


"1/ 🤯 Big news for biotech: Google / DeepMind just released a 27B-parameter foundation model (C2S-Scale 27B) for single-cell analysis and used it to discover a novel experimentally validated cancer immunotherapy hypothesis"  
[X Link](https://x.com/flobrand/status/1978754644244337129) [@flobrand](/creator/x/flobrand) 2025-10-16T09:27Z 3415 followers, XXX engagements


"1/ Big congrats to my Co-Founder @SriniGRao @C_Angermayer Cosmo and the entire teams at @ataiLife & @BeckleyPsytech on receiving FDA Breakthrough Therapy Designation (BTD) for BPL-003 (5-MeO-DMT) in treatment-resistant depression 👏 🔗"  
[X Link](https://x.com/flobrand/status/1978939825970364671) [@flobrand](/creator/x/flobrand) 2025-10-16T21:43Z 3412 followers, 1336 engagements


"5/ This suggests markets may still underestimate the probability of success (PoS) of BTD assets. And psychedelics like BPL-003 may be further derisked given their growing late-stage clinical evidence across multiple programs. 🧠"  
[X Link](https://x.com/flobrand/status/1978939837182050801) [@flobrand](/creator/x/flobrand) 2025-10-16T21:43Z 3411 followers, XXX engagements


"6/ Exciting times ahead for short-acting psychedelics and the future of in-clinic mental-health treatments. 🌄 #Psychedelics #Biotech #FDA #MentalHealth #BTD #BPL003 #TRD"  
[X Link](https://x.com/flobrand/status/1978939839874544085) [@flobrand](/creator/x/flobrand) 2025-10-16T21:43Z 3411 followers, XXX engagements